Gsa Capital Partners LLP Sera Prognostics, Inc. Put Options Transaction History
Gsa Capital Partners LLP
- $1.2 Billion
- Q3 2025
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding SERA
# of Institutions
64Shares Held
21.9MCall Options Held
0Put Options Held
0-
Baker Bros. Advisors LP New York, NY5.5MShares$16.3 Million0.14% of portfolio
-
Whetstone Capital Advisors, LLC Shawnee Mission, KS3.63MShares$10.8 Million3.75% of portfolio
-
Interwest Venture Management CO2.42MShares$7.15 Million21.78% of portfolio
-
Abrdn PLC2.28MShares$6.75 Million0.01% of portfolio
-
Vivo Capital, LLC Palo Alto, CA1.65MShares$4.89 Million0.8% of portfolio
About SERA PROGNOSTICS, INC.
- Ticker SERA
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 29,596,900
- Market Cap $87.6M
- Description
- Sera Prognostics, Inc., a women's health diagnostic company, discovers, develops, and commercializes biomarker tests for improving pregnancy outcomes. The company develops PreTRM test, a blood-based biomarker test to predict the risk of spontaneous preterm birth in asymptomatic singleton pregnancies. It is also developing a portfolio of product ...